Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Body Composition and Risk of Vascular-Metabolic Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic Disease.

Gnatiuc Friedrichs L. et al, (2023), J Am Heart Assoc

Genetically Predicted Differences in Systolic Blood Pressure and Risk of Cardiovascular and Noncardiovascular Diseases: A Mendelian Randomization Study in Chinese Adults.

Clarke R. et al, (2023), Hypertension

Mechanisms and Predictors of Acute Kidney Injury with Perioperative Rosuvastatin in Patients Undergoing Cardiac Surgery

Wijesurendra RS. et al, (2023)

Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation.

Bowman L. et al, (2022), Circulation

Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study.

Chan KH. et al, (2022), Lancet Public Health, 7, e1014 - e1026

UK Biobank: a globally important resource for cancer research.

Conroy MC. et al, (2022), Br J Cancer

Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes.

Nag A. et al, (2022), Sci Adv, 8

Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults.

Aguilar-Ramirez D. et al, (2022), Commun Med (Lond), 2

How UK Biobank is democratising access to large-scale genomic and phenotypic data for discovery science

LACEY B. et al, (2022)

Stroke genetics informs drug discovery and risk prediction across ancestries.

Mishra A. et al, (2022), Nature

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.

Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 645 - 654

Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.

Akbari P. et al, (2022), Nat Commun, 13

New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders.

Bešević J. et al, (2022), J Clin Endocrinol Metab, 107, 2403 - 2410

Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy

BAIGENT C. et al, (2022), The Lancet

Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.

Cholesterol Treatment Trialists' Collaboration None., (2022), Clin Trials

Genotyping, sequencing and analysis of 140,000 adults from the Mexico City Prospective Study

Ziyatdinov A. et al, (2022)

Body mass index and COVID-19 mortality: prospective study of 120 000 Mexican adults.

Alegre-Díaz J. et al, (2022), Int J Epidemiol

Coarse Grain Consumption and Risk of Cardiometabolic Diseases: A Prospective Cohort Study of Chinese Adults.

Yang J. et al, (2022), J Nutr, 152, 1476 - 1486

Global priorities for large-scale biomarker-based prospective cohorts.

Collins R. et al, (2022), Cell Genom, 2

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?